GINO BIOW Stock Nasdaq
Equities
DNA
US37611X1000
Biotechnology & Medical Research
Financials (USD)
Sales 2024 * | 223M | Sales 2025 * | 310M | Capitalization | 2.1B |
---|---|---|---|---|---|
Net income 2024 * | -631M | Net income 2025 * | -534M | EV / Sales 2024 * | 6.4 x |
Net cash position 2024 * | 676M | Net cash position 2025 * | 550M | EV / Sales 2025 * | 5.02 x |
P/E ratio 2024 * |
-2.98
x | P/E ratio 2025 * |
-3.52
x | Employees | 1,218 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 69.13% |
Latest transcript on GINO BIOW
Managers | Title | Age | Since |
---|---|---|---|
Austin Che
FOU | Founder | - | 07-12-31 |
Founder | - | 07-12-31 | |
Reshma Shetty
FOU | Founder | 43 | 07-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Christian Henry
BRD | Director/Board Member | 56 | 21-09-15 |
Arie Belldegrun
BRD | Director/Board Member | 74 | 20-12-31 |
Marijn Dekkers
CHM | Chairman | 65 | 21-09-15 |
1st Jan change | Capi. | |
---|---|---|
+25.69% | 47.86B | |
+46.90% | 41.42B | |
-3.46% | 40.66B | |
-6.20% | 28.92B | |
+9.17% | 25.55B | |
-20.42% | 19.27B | |
+0.17% | 12.15B | |
+28.07% | 12.14B | |
-1.24% | 11.99B |